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A B S T R A C T
As one of the important dietary antioxidants, (-)-epicatechin is a potent reactive oxygen species (ROS) scavenger
involved in the redox modulation of the cell. When scavenging ROS, (-)-epicatechin will donate two electrons
and become (-)-epicatechin quinone, and thus take over part of the oxidative potential of the ROS. The aim of the
study is to determine where this chemical reactivity resides in (-)-epicatechin quinone. When this reactivity is
spread out over the entire molecule, i.e. over the AC-ring and B-ring, this will lead to partial epimerization of
(-)-epicatechin quinone to (-)-catechin quinone. In our experiments, (-)-epicatechin quinone was generated with
tyrosinase. The formation of (-)-epicatechin quinone was conﬁrmed by trapping with GSH, and identiﬁcation of
(-)-epicatechin-GSH adducts. Moreover, (-)-epicatechin quinone could be detected using Q-TOF/MS despite its
short half-life. To detect the epimerization, the ability of ascorbate to reduce the unstable ﬂavonoid quinones
into the corresponding stable ﬂavonoids was used. The results showed that the reduction of the formed
(-)-epicatechin quinone by ascorbate did not result in the formation of an appreciable amount of (-)-catechin.
Therefore it can be concluded that the chemical reactivity of (-)-epicatechin quinone mainly resides in its B-ring.
This could be corroborated by quantum chemical calculations. Understanding the stabilization of the (-)-epi-
catechin quinone will help to diﬀerentiate between ﬂavonoids and to select the appropriate compound for a
speciﬁc disorder.
1. Introduction
Reactive oxygen species (ROS) are byproducts of oxygen metabo-
lism in our body and can damage critical molecules in a cell [1,2]. To
protect DNA, proteins, lipids and other vital cellular constituents
against ROS damage, our cells are equipped with an intricate anti-
oxidant defense system. However, when ROS production outbalances
the defense system, the resulting oxidative stress will induce cell da-
mage. This is a process pivotal in numerous diseases like cardiovascular
diseases, arthritis, cancer, chronic inﬂammation, diabetes, aging, neu-
rological and neurodegenerative disorders [3–5]. Many studies have
proved that dietary antioxidants support the defense system in dealing
with oxidative stress, and the intake of dietary antioxidants is asso-
ciated with a lower risk of oxidative stress induced diseases [6,7].
Polyphenols form a major group of dietary antioxidants. For several
decades, they have been in the spotlight because of their potent
antioxidant activity, which is linked to their anti-proliferative, anti-
diabetic, anticancer, anti-microbial, anti-inﬂammatory and antiviral
activity [8,9]. During oxidative stress, the polyphenols quickly react
with the ROS [10,11]. In this direct scavenging reaction, the poly-
phenols donate electrons to ROS, and oxidation products, quinones, are
generated [12–14]. Although relatively stable compared to ROS, these
quinones have taken over part of the oxidative potential of the ROS. For
example, they can react with thiols present in glutathione (GSH) and
cellular proteins [15–17].
In the present study, we selected one of the most important poly-
phenolic compounds, i.e. (-)-epicatechin [18,19]. The aim is to de-
termine where the chemical reactivity resides in the (-)-epicatechin
quinone. Based on its chemical structure, (-)-epicatechin quinone might
be stabilized by the tautomerization as depicted in Fig. 1. This means
that the reactivity is spread over the AC-ring and B-ring. If the proposed
tautomerization takes place, this will lead to the partial epimerization
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of (-)-epicatechin quinone to (-)-catechin quinone. In the antioxidant
network, the relatively unstable ﬂavonoid quinones can be recycled by
ascorbate to the corresponding stable ﬂavonoids. Therefore oxidation of
(-)-epicatechin, followed by the epimerization and the reduction of the
(-)-epicatechin quinone by ascorbate, will lead to the formation of
(-)-catechin out of (-)-epicatechin. We determined the extent of epi-
merization of (-)-epicatechin to (-)-catechin during this oxidation / re-
duction cycle. This helps to understand where the oxidative potential of
(-)-epicatechin quinone resides within the molecule. Understanding the
stabilization of the quinones will help us to diﬀerentiate between
polyphenolics and to select the appropriate compound for a speciﬁc
disorder. Moreover, the epimerization of (-)-epicatechin to (-)-catechin
would be a tool to evaluate the antioxidant activity and recycling of
(-)-epicatechin in biological systems.
2. Materials and methods
2.1. Chemicals
(-)-Epicatechin, (-)-catechin, tyrosinase, ascorbate and GSH were
purchased from Sigma (St. Louis, MO, USA) and dissolved in assay
buﬀer (100mM ammonium bicarbonate, pH 7.4).
2.2. (-)-Epicatechin oxidation
The oxidation of 50 µM (-)-epicatechin was performed at 37 °C in
the assay buﬀer and started by adding 10 U/mL tyrosinase. After
starting the oxidation, the UV absorption spectrum (λ=200–600 nm)
was recorded every 2min for 10min (see legend of Fig. 2). In parallel,
50 µM ascorbate or 100 µM GSH were added to (-)-epicatechin before
starting the reaction [14,20]. The ascorbate consumption was de-
termined from the absorption at 270 nm using a molar extinction
coeﬃcient of 3640M−1 ∙cm−1. The reactions were ﬁrst monitored
spectrophotometrically for 5min and then analyzed with HPLC and
UHPLC-Q-TOF/MS.
2.3. HPLC analysis
High performance liquid chromatography (HPLC) coupled to ul-
traviolet detection at 230 nm was performed using an Agilent 1260
HPLC system and a diode array detector (Agilent Technologies, Santa
Clara (CA), USA). An Apollo C18 column (150× 4.60mm i.d., 5 µm)
was used. The mobile phase was composed of solvent A (H2O) and
solvent B (acetonitrile). The gradient program was: 0–2min: 96–92% A,
2–11min: 92–75% A. After each injection, 90% of B was used to wash
the column for 5min, and the column was reequilibrated with 4% of B
for 5min. The ﬂow rate was 1.0 mL/min and 20 µL of samples were
injected [21,22].
2.4. UHPLC-ESI-Q-TOF/MS and MS/MS analysis
The reaction products were separated using an Agilent 1290 inﬁnity
ultrahigh performance liquid chromatography (UHPLC) system (Agilent
Technologies, Santa Clara (CA), USA). The UHPLC was equipped with a
quaternary pump with an integrated vacuum degasser (G4204A), an
autosampler (G4226A) with a thermostat (G1330B), and a thermo-
statted column compartment (G1316C). An Agilent Extend C18 column
(2.1× 50mm, 1.8 µm), with an Agilent Eclipse plus C18 guard column
(2.1× 5mm, 1.8 µm), was selected as the stationary phase. The mobile
phase consists of a mixture of 0.1% (v/v) formic acid in water (solvent
A) and acetonitrile (solvent B).
The ﬂow rate was set to 0.4mL/min, and the column temperature
was maintained at 25 °C. The gradient elution started with 10% B, in-
creased linearly to 35% B over 4min, and continued to increase to 75%
solvent B over 4.75min before decreasing to 10% B over 5.50min. An
equilibrium period of 1.25min was used between two injections. The
injection volume was 10 µL.
(-)-Epicatechin metabolites were detected using an Agilent 6550
iFunnel Accurate-Mass Quadrupole Time-of-Flight Mass Spectrometer
(Q-TOF/MS) equipped with Dual Agilent Jet Stream technology for


























































Fig. 1. The investigated epimerization of (-)-epicatechin to (-)-catechin under the interplay of tyrosinase and ascorbate. (-)-Epicatechin is oxidized by tyrosinase to
form (-)-epicatechin quinone. Three possible tautomeric forms for the quinone are depicted and include (-)-epicatechin quinone and (-)-catechin quinone. Reduction
of (-)-epicatechin quinone by ascorbate gives (-)-epicatechin. Reduction of (-)-catechin quinone by ascorbate gives (-)-catechin. If the proposed oxidation, tauto-
merizaion and recycling takes place, this will lead to partial epimerization of (-)-epicatechin to (-)-catechin.
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The capillary voltage was set to 2500 V. The temperature and ﬂow rate
of the drying gas were set to 150 °C and 20 L/min, respectively, while
the temperature and ﬂow rate of the sheath gas were 350 °C and 12 L/
min, respectively. The nebulizer pressure was controlled to 25 psi. The
mass range for the TOF scanning was set to 50–1700m/z.
Peaks of eluents corresponding to (-)-epicatechin and (-)-epicatechin
metabolites were subjected to Q-TOF MS/MS analysis to achieve a high
mass accuracy. The collision energies were ﬁxed to 35 and 32 for
(-)-catechin and (-)-epicatechin, respectively. The m/z range for the
targeted MS/MS acquisition was set to 50–1700m/z in negative ESI
mode. The mass accuracy was constantly checked via online calibration
using a calibration solution containing the internal reference ions at m/
z at 112.9855 and 1033.9881in negative ionization mode. Data were
analyzed and processed using Agilent Mass Hunter Workstation
Quantitative and Qualitative Analysis software B.06.01. Structure
conﬁrmation of epicatechin metabolites was obtained by Agilent Mass
Hunter structure correlator software [23,24].
2.5. LUMO map of (-)-epicatechin quinone
Quantum molecular calculations were performed using Spartan ’16
to analyze the tautomers of the oxidized (-)-epicatechin. The Lowest
Unoccupied Molecular Orbital (LUMO) energies (kJ/mol) of the tau-
tomers of (-)-epicatechin quinone were calculated as well as their
equilibrium geometry under Hartree-Fock (HF) 6-31G* basis set. The
dihedral angles between the plane of the AC-ring and that of the B-ring
of (-)-epicatechin quinones were also determined [17,25].
2.6. Statistics
All experiments were performed at least in triplicate. Results are
shown as mean ± standard error of the mean (S.E.M.) or as a typical
example.
3. Results
3.1. (-)-Epicatechin is oxidized by tyrosinse into (-)-epicatechin quinone
Addition of tyrosinase to (-)-epicatechin resulted in the oxidation of
(-)-epicatechin, which was evident from the change in the UV spectrum
(Fig. 2A). HPLC analysis of the incubation mixture conﬁrmed that
(-)-epicatechin was consumed during the oxidation process (Fig. 3B).
The Q-TOF MS/MS analysis showed that (-)-epicatechin quinone was
formed (Fig. 4B). (-)-Epicatechin quinone yielded fragment ions at
288.06m/z, 177.05m/z, 161.02m/z and 125.02m/z. The protonated
and fragmented ions of (-)-epicatechin were 289.07m/z, 109.03m/z
and 123.05m/z (Fig. 4A). The diastereoisomers, (-)-epicatechin and
(-)-catechin, gave almost the same fragment ions indicating that the
isomers could not be distinguished by only using their mass spectra.
Using HPLC analysis, (-)-epicatechin and (-)-catechin showed a rela-
tively large diﬀerence in the retention time, which were 10.6 min and
9.1 min respectively (Fig. 3). This was used to selectively detect both
diastereoisomers.
3.2. The conﬁrmation of the formation of (-)-epicatechin quinone
When (-)-epicatechin is oxidized by tyrosinase in the presence of
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Fig. 2. The UV spectra of the incubation mixture containing 50 µM (-)-epicatechin and 10 U/mL tyrosinase (A). The same experiment was carried out in the presence
of 100 µM GSH (B) or 50 µM ascorbate (C). The reaction was started by the addition of tyrosinase. UV scans were recorded every 2min after starting the reaction. The
insert shows the diﬀerence in absorption of each scan compared with that of the ﬁrst scan. A typical example is shown.
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GSH, the change in the UV spectrum indicated that (-)-epicatechin-GSH
adducts were formed (Fig. 2B). HPLC analysis shows new peaks in the
chromatogram at 2.9 and 3.4 min (Fig. 3C) also indicating the forma-
tion of GSH adducts. Q-TOF/MS analysis of (-)-epicatechin interacting
with tyrosinase and GSH conﬁrms the presence of (-)-epicatechin-GSH
adducts, based on the characteristic fragment ions of (-)-epicatechin-
GSH of 594.14m/z, 272.09m/z, 143.05m/z and 321.04m/z (Fig. 4C).
Matching the observed MS/MS fragments with the proposed structure
provides additional evidence for the formation of (-)-epicatechin-GSH
adducts (Fig. 5). The formation of (-)-epicatechin-GSH adducts conﬁrms
that tyrosinase converts (-)-epicatechin into its quinone. It is concluded
that (-)-epicatechin is ﬁrst converted into (-)-epicatechin quinone, and
subsequently the quinone reacts with GSH into (-)-epicatechin-GSH
adducts.
3.3. No epimerization of (-)-epicatechin quinone to (-)-catechin quinone
When (-)-epicatechin is oxidized by tyrosinase in the presence of
ascorbate, the UV recordings indicate that there is no net consumption
of (-)-epicatechin. However, the spectral change observed at 270 nm
indicates that ascorbate is greatly consumed in the presence of
(-)-epicatechin and tyrosinase (Fig. 2C). The rate of ascorbate con-
sumption with (-)-epicatechin and tyrosinase (2.22 ± 0.06 µM/min) is
much higher than that of ascorbate with tyrosinase (0.60 ± 0.03 µM/
min) (Fig. 6). HPLC analysis conﬁrmed that hardly any net oxidation of
(-)-epicatechin by tyrosinase occurs in the presence of ascorbate
(Fig. 3D). These results indicate that in the incubation with ascorbate,
(-)-epicatechin is ﬁrst oxidized into (-)-epicatechin quinone and that the
quinone immediately reacts with ascorbate to regenerate (-)-epica-
techin. Assuming that ascorbate and (-)-epicatechin quinone react 1:1,
the rate of (-)-epicatechin quinone formation equals to ascorbate con-
sumption by tyrosinase, which is 1.63 ± 0.07 µM/min (Fig. 5).
When (-)-epicatechin is oxidized by tyrosinase in the presence of
ascorbate, (-)-epicatechin quinone is formed. This quinone might be
stabilized by epimerization, with the tautomeric forms given in Fig. 1.
In the quinone intermediate, the C2-C1' bound changes from a single
bound to a double bound. Converting this double bound back to a single
bound can be achieved in two manners and therefore this would lead to
(partial) epimerization at the asymmetric C2 carbon. This would result
in (partial) conversion of (-)-epicatechin quinone into (-)-catechin
A (-)-Epicatechin
B (-)-Epicatechin +Tyrosinase  
C (-)-Epicatechin + Tyrosinase + GSH







Fig. 3. HPLC chromatograms of 50 µM (-)-epicatechin (A) and 50 µM (-)-catechin (E) calibration standard, and of the incubation mixture containing 50 µM
(-)-epicatechin and 10 U/mL tyrosinase (B), in presence of 50 µM ascorbate (C) or 100 µM GSH (D). The incubation mixtures were injected into the HPLC system
5min after starting the reaction with tyrosinase. The retention time of (-)-epicatechin and (-)-catechin are 10.6 and 9.1, respectively. The consumption of (-)-epi-
catechin in B, C and D is 16.71 ± 1.34 µM, 17.041 ± 2.24 µM and 3.04 ± 0.76 µM, respectively.
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quinone. Due to the limited stability of the quinone, this was not ex-
amined directly by examining the epimerization of the quinone itself.
In the presence of ascorbate, the quinone is not degraded but im-
mediately reduced. If the epimerization of the quinone would take
place, the reduction of the quinone by ascorbate would yield (-)-ca-
techin as well as (-)-epicatechin. As described above, the epimerization
of (-)-epicatechin to (-)-catechin can be examined using HPLC since
they are diastereoisomers.
Fig. 4. Q-TOF MS/MS spectra of (-)-epicatechin (A), (-)-epicatechin quinone (B) and (-)-epicatechin-GSH adducts (C) with characteristic fragment ions.
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In the incubation of (-)-epicatechin with tyrosinase and ascorbate,
no appreciable amount of (-)-catechin was detected using HPLC. This
indicates that there is no substantial epimerization of (-)-epicatechin
and (-)-catechin during oxidation. In Supplementary information, the
LC/MS chromatograms obtained in conformation of the identity of the
(-)-epicatechin quinone and (-)-epicatechin-GSH adducts, are shown. A
trace of (-)-catechin was detected in the incubation of (-)-epicatechin
with tyrosinase and ascorbate. A similar trace of (-)-catechin was de-
tected in the (-)-epicatechin calibration standard and in the incubation
of (-)-epicatechin without tyrosinase and ascorbate. That only traces of
(-)-catechin were detected conﬁrms the HPLC result that no substantial
epimerization takes place.
3.4. The LUMO energy of (-)-epicatechin quinone
In the oxidative activity of (-)-epicatechin quinone, the LUMO ac-
cepts the electrons and is thus pivotal in its reactivity. In Fig. 7, it is
shown how the energy of the LUMO orbital is distributed over the
molecule in the three tautomers of (-)-epicatechin quinone. With the
energy of 136.04 kJ/mol, the LUMO of quinone intermediate is located
in B-ring and for a small part also located in the C-ring. The LUMO of
(-)-epicatechin quinone and (-)-catechin quinone are concentrated in B-
ring, and their energies are 44.38 kJ/mol and 36.66 kJ/mol respec-
tively. The high energy diﬀerence between (-)-epicatechin quinone
(44.38 kJ/mol) and the quinone intermediate (136.04 kJ/mol) in-
dicates that the formation of quinone intermediate is not likely to occur.
The calculations also show that there is a relatively large diﬀerence in
the dihedral angle between the three tautomers of (-)-epicatechin qui-
none. The large diﬀerence in dihedral angle between (-)-epicatechin
quinone and the quinone intermediate also indicates that there is no
substantial isomerization. This further corroborates that the chemical
reactivity of (-)-epicatechin quinone mainly resides in its B-ring.
4. Discussion





































Fig. 5. Fragmentation patterns for (-)-epicatechin, (-)-epicatechin quinone and (-)-epicatechin-GSH adducts obtained from the MS/MS spectra using MassHunter MSC
software. The chemical structures of the fragments are highlighted in black within the chemical structure of the parent molecules.
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support the cellular defense system in dealing with oxidative stress
[26]. (-)-Epicatechin, one of the most important dietary antioxidants,
has gained signiﬁcant attention because of its potent antioxidant ac-
tivity [27]. It has been proved that the B-ring of (-)-epicatechin, a ca-
techol moiety, is essential for its direct antioxidant activity to scavenge
ROS [28]. When scavenging ROS, (-)-epicatechin will be oxidized into
its two-electron oxidation product, (-)-epicatechin quinone. This qui-
none is much less reactive than the ROS scavenged, which is pivotal in
the redox modulating eﬀect of (-)-epicatechin [29]. Nevertheless, this
quinone has taken over part of the reactivity of the ROS scavenged, and
it can react e.g. with thiol groups. The research aim of the study is to
unravel one aspect of (-)-epicatechin quinone, namely its stabilization.
Looking at its chemical structure, (-)-epicatechin quinone might be
stabilized by the tautomerization as depicted in Fig. 1.
In present study, (-)-epicatechin quinone was formed using tyr-
osinase. GSH is known to adduct quinones. The formation of (-)-epi-
catechin quinone was supported by the (-)-epicatechin-GSH adducts
found when GSH was added to the incubation of (-)-epicatechin with
tyrosinase. The formed (-)-epicatechin-GSH adducts were detected
using UV, HPLC and Q-TOF /MS. Moreover, the formation of (-)-epi-
catechin quinone was also conﬁrmed with Q-TOF /MS detection. To our
knowledge this is the ﬁrst time that (-)-epicatechin quinone was directly
detected.
Quinones of polyphenols have a short half-life. Therefore, ascorbate
was used to reduce the quinones formed during the tyrosinase catalyzed
oxidation of (-)-epicatechin to the corresponding more stable poly-
phenols. If the tautomerization of the (-)-epicatechin quinone to the
(-)-catechin quinone occurs (as depicted in Fig. 1), the reduction by
ascorbate will result not only in the recycling of (-)-epicatechin, but also
in the formation of (-)-catechin.
That ascorbate indeed directly reduces the (-)-epicatechin quinone
formed into (-)-epicatechin is shown by the UV and HPLC results of the
incubation mixture containing (-)-epicatechin, tyrosinase and ascor-
bate. In this incubation system, ascorbate is consumed, while (-)-epi-
catechin is instantaneously recycled and therefore the concentration of
(-)-epicatechin stays the same. The HPLC coupled with UV detection
does not show the formation of a detectible amount of (-)-catechin. This
indicates that no appreciable epimerization of (-)-epicatechin quinone
to (-)-catechin quinone occurs.
The LC/MS chromatograms presented in Supplementary informa-
tion shows that a trace of (-)-catechin was detected in the incubation
mixture of (-)-epicatechin with tyrosianse and ascorbate. Similarly, a
trace of (-)-catechin was also detected in the (-)-epicatechin calibration
standard and in the incubation of (-)-epicatechin without tyrosinase and
ascorbate. The later ﬁndings indicate that the trace amount of (-)-ca-
techin found are formed by “spontaneous epimerization” of (-)-epica-
techin.


























Fig. 6. The rate of ascorbate consumption and (-)-epicatechin quinone forma-
tion in the incubation mixture containing 50 µM ascorbate, 10 U/mL tyrosinase
or 50 µM (-)-epicatechin. The reaction was started with the addition of tyr-
osinase. Ascorbate consumption was calculated from the reduction in the ab-
sorption at 270 nm using a molar extinction coeﬃcient of 3640M−1 ∙cm−1. The
diﬀerence between the ascorbate consumption with and without (-)-epicatechin
was ascribed to reduction of the (-)-epicatechin quinone generated by the tyr-
osinase catalyzed oxidation of (-)-epicatechin. This was used to estimate the
rate of (-)-epicatechin quinone formation.
Fig. 7. The tautomers of (-)-epicatechin qui-
none, their Lowest Unoccupied Molecular
Orbital (LUMO) map, and dihedral angle be-
tween the plane of the AC-ring and that of the
B-ring. In depicting the dihedral angle, only C2
and C3 of the AC-ring are shown for sake of
clarity. The large diﬀerence in the dihedral
angle is indicative for the high energy barrier
between the tautomers and can explain why
the proposed tautomerization does not take
place.
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quinone, the relatively big diﬀerence in the dihedral angle (the angle
between the plane of AC-ring and that of the B-ring) between (-)-epi-
catechin quinone and the quinone intermediate will cause an energy
barrier that is hard to overcome. In the spontaneous epimerization of
(-)-epicatechin (dihedral angle−57.03°) to (-)-catechin (dihedral angle
−55.74°), the overall change in dihedral angle is similar to that of the
corresponding quinones (from −55.96° to 55.55°, Fig. 7). A diﬀerence
is that the C-ring is opened in the intermediate of the spontaneous
isomerization (Fig. 8) and there is no ﬁxed “dihedral angle” between
the ring systems because the C-ring is not a ring anymore [30]. This
makes the quinone intermediate of spontaneous isomerization much
more ﬂexible than the rigid quinone intermediate depicted in Fig. 1.
Therefore, the conformational change from (-)-epicatechin to the ﬂex-
ible intermediate is relatively small compared to the big conformational
change from (-)-epicatechin quinone to the rigid quinone intermediate.
This suggests that the spontaneous epimerization of (-)-epicatechin is
quicker than the epimerization of (-)-epicatechin quinone. Actually,
that only traces of (-)-catechin were detected conﬁrms the HPLC data
that no substantial epimerization takes place.
The reactivity of (-)-epicatechin quinone, that is primarily due to its
ability to easily accept electrons, was also evaluated by constructing its
LUMO map. It shows that the LUMO energy of (-)-epicatechin quinone
is indeed concentrated in the B-ring. Within the B-ring, the most elec-
tron deﬁcient positions of (-)-epicatechin quinone are on the 2', 5' and 6'
position. Consequently, nucleophiles such as GSH are expected to ad-
duct to the B-ring at these positions. Previously, it has been reported
that indeed these mono GSH adducts in B-ring are formed [31]. This
further conﬁrms that the chemical reactivity of (-)-epicatechin quinone
primarily resides in B-ring.
When quercetin, another important polyphenol, is oxidized, it will
also generate a quinone that can react with thiols. In contrast to
(-)-epicatechin quinone, GSH will adduct to the 6 and 8 position of the
A-ring of quercetin quinone. This indicates that the chemical reactivity
of quercetin quinone does not reside only in B-ring but is spread out
over the AC-ring as well as the B-ring, so over the entire molecule
[14,32]. With a high concentrated electron density in B-ring, (-)-epi-
catechin quinone is harder than quercetin quinone that has its electron
density spread over the molecule. According to Pearson's Hard and Soft
Acids and Bases concept, ‘hard’ electrophiles will more likely react with
‘hard’ nucleophiles and ‘soft’ electrophiles will more likely react with
‘soft’ nucleophiles [33]. It is obvious that such a diﬀerence in chemical
reactivity between these bioactives will be reﬂected in a diﬀerence in
their biological eﬀects. However, this is still mainly a “terra incognita”.
The present study is a step further in the diﬀerentiation between
bioactive polyphenols to ﬁnally come up with a rational selection for
the appropriate compound for a speciﬁc disorder. We would like to
stress that the diﬀerence between ‘hard’ and ‘soft’ redox modulating
compounds should be acknowledged and further elaborated in clinical
studies with polyphenols.
5. Conclusions
(-)-Epicatechin oxidation involves two electron oxidation of its B-
ring, giving (-)-epicatechin quinone. Our results show that there is no
epimerization of (-)-epicatechin quinone and (-)-catechin quinone in
the oxidation process. Therefore, it is concluded that the chemical re-
activity of (-)-epicatechin quinone mainly resides in its B-ring.
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